Hong Kong SPAC nixes diagnostics merger; Clay Siegall will run a public biotech again
HH&L Acquisition Co., a SPAC that went through a $360 million IPO in early 2021, has reneged on its business combination agreement.
The Hong Kong …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
